65(top 100%)
PR articles
2.5K(top 10%)
PR citations
27(top 100%)
PR h-index
29(top 100%)
h-index
74
documents
3.8K
doc citations
993
citing journals
100
times ranked

Publications

65 PR articles • 2,627 PR citations • Sorted by year • Download PDF (PDF by citations)
#ArticleIFPR CitationsLinks
1Longitudinal Assessment of Pancreas Volume by MRI Predicts Progression to Stage 3 Type 1 Diabetes
Diabetes Care, 2024, 47, 393-400
10.118Citations (PDF)
2A loss-of-function mutation in KCNJ11 causing sulfonylurea-sensitive diabetes in early adult life
Diabetologia, 2024, 67, 940-951
8.28Citations (PDF)
3Precision treatment of beta-cell monogenic diabetes: a systematic review5.112Citations (PDF)
4Acute Recurrent Pancreatitis in a Child with INS-related Monogenic Diabetes and a Heterozygous Pathogenic CFTR Mutation0.20Citations (PDF)
5Novel <i>KDM6A</i> Kabuki Syndrome Mutation With Hyperinsulinemic Hypoglycemia and Pulmonary Hypertension Requiring ECMO0.213Citations (PDF)
6Development of a standardized MRI protocol for pancreas assessment in humans
PLoS ONE, 2021, 16, e0256029
2.418Citations (PDF)
7Monogenic Diabetes: From Genetic Insights to Population-Based Precision in Care. Reflections From a <i>Diabetes Care</i> Editors’ Expert Forum
Diabetes Care, 2020, 43, 3117-3128
10.192Citations (PDF)
8Update of variants identified in the pancreatic β‐cell K <sub>ATP</sub> channel genes <i>KCNJ11</i> and <i>ABCC8</i> in individuals with congenital hyperinsulinism and diabetes
Human Mutation, 2020, 41, 884-905
3.9153Citations (PDF)
9Congenital hyperinsulinism as the presenting feature of Kabuki syndrome: clinical and molecular characterization of 10 affected individuals
Genetics in Medicine, 2019, 21, 233-242
4.449Citations (PDF)
10Precision Medicine: Long-Term Treatment with Sulfonylureas in Patients with Neonatal Diabetes Due to KCNJ11 Mutations5.520Citations (PDF)
11Iatrogenic Hyperinsulinemia, Not Hyperglycemia, Drives Insulin Resistance in Type 1 Diabetes as Revealed by Comparison With GCK-MODY (MODY2)
Diabetes, 2019, 68, 1565-1576
0.552Citations (PDF)
12Trisomy 21 Is a Cause of Permanent Neonatal Diabetes That Is Autoimmune but Not HLA Associated
Diabetes, 2019, 68, 1528-1535
0.532Citations (PDF)
13184-LB: Pancreatic Hypoplasia Patients Experience Poor Weight Gain and Labile Diabetes without Diabetic Ketoacidosis (DKA)
Diabetes, 2019, 68,
0.50Citations (PDF)
14124-LB: Patients’ Experiences with a Do-It-Yourself Artificial Pancreas and Perspectives of the Endocrinologist’s Role in Supporting Their Use
Diabetes, 2019, 68,
0.50Citations (PDF)
15Congenital forms of diabetes: the beta-cell and beyond3.320Citations (PDF)
16Early Intensive Insulin Use May Preserve β-Cell Function in Neonatal Diabetes Due to Mutations in the Proinsulin Gene0.214Citations (PDF)
17Neonatal Diabetes Mellitus
Clinics in Perinatology, 2018, 45, 41-59
1.8168Citations (PDF)
18Pancreatic Histopathology of Human Monogenic Diabetes Due to Causal Variants in KCNJ11, HNF1A, GATA6, and LMNA4.222Citations (PDF)
19<i>FOXP3</i> mutations causing early‐onset insulin‐requiring diabetes but without other features of immune dysregulation, polyendocrinopathy, enteropathy, X‐linked syndrome
Pediatric Diabetes, 2018, 19, 388-392
4.629Citations (PDF)
20Hypoglycemia in sulfonylurea‐treated <i>KCNJ11</i> ‐neonatal diabetes: Mild‐moderate symptomatic episodes occur infrequently but none involving unconsciousness or seizures
Pediatric Diabetes, 2018, 19, 393-397
4.625Citations (PDF)
21ISPAD Clinical Practice Consensus Guidelines 2018: The diagnosis and management of monogenic diabetes in children and adolescents
Pediatric Diabetes, 2018, 19, 47-63
4.6274Citations (PDF)
22Monogenic diabetes: the impact of making the right diagnosis2.418Citations (PDF)
23Congenital Diabetes: Comprehensive Genetic Testing Allows for Improved Diagnosis and Treatment of Diabetes and Other Associated Features5.515Citations (PDF)
24Management and pregnancy outcomes of women with GCK-MODY enrolled in the US Monogenic Diabetes Registry
Acta Diabetologica, 2018, 56, 405-411
2.757Citations (PDF)
25Insulin Treatment and Clinical Outcomes in 67 Participants with Infancy-Onset Diabetes
Diabetes, 2018, 67, 1379-P
0.50Citations (PDF)
26Management of GCK-MODY in Pregnancy—Does Clinical Practice Follow Current Recommendations?
Diabetes, 2018, 67,
0.51Citations (PDF)
27White Matter Differences and Neurodevelopment Outcomes in Patients with KATP Channel-Related Diabetes
Diabetes, 2018, 67, 157-LB
0.50Citations (PDF)
28Clinical Utility of the T1D Genetic Risk Score—Examples from the U.S. Monogenic Diabetes Registry
Diabetes, 2018, 67, 264-OR
0.50Citations (PDF)
29Identifying Patients with GDM at Risk for GCK-MODY
Diabetes, 2018, 67,
0.50Citations (PDF)
30Case Report: Preservation of Reduced Numbers of Insulin-Positive Cells in Sulfonylurea-Unresponsive <i>KCNJ11</i>-related Diabetes4.224Citations (PDF)
31Diabetes Presentation in Infancy: High Risk of Diabetic Ketoacidosis
Diabetes Care, 2017, 40, e147-e148
10.158Citations (PDF)
32ADHD, learning difficulties and sleep disturbances associated with <i>KCNJ11</i> -related neonatal diabetes
Pediatric Diabetes, 2017, 18, 518-523
4.639Citations (PDF)
33Long Delay in Accurate Diagnosis of Hnf1A-Mody in the us Monogenic Diabetes Registry1.81Citations (PDF)
34Role of Noninsulin Therapies Alone or in Combination in Chromosome 6q24-Related Transient Neonatal Diabetes: Sulfonylurea Improves but Does Not Always Normalize Insulin Secretion
Diabetes Care, 2015, 38, e86-e87
10.129Citations (PDF)
35Age at the time of sulfonylurea initiation influences treatment outcomes in KCNJ11-related neonatal diabetes
Diabetologia, 2015, 58, 1430-1435
8.279Citations (PDF)
36An online monogenic diabetes discussion group: supporting families and fueling new research
Translational Research, 2015, 166, 425-431
4.26Citations (PDF)
37Response Letter to the Editor4.20Citations (PDF)
38Neonatal diabetes, gallbladder agenesis, duodenal atresia, and intestinal malrotation caused by a novel homozygous mutation in<i>RFX6</i>
Pediatric Diabetes, 2014, 15, 67-72
4.668Citations (PDF)
39Microcephaly, epilepsy, and neonatal diabetes due to compound heterozygous mutations in<i>IER3IP1</i>: insights into the natural history of a rare disorder
Pediatric Diabetes, 2014, 15, 252-256
4.651Citations (PDF)
40Sulfonylurea Treatment Before Genetic Testing in Neonatal Diabetes: Pros and Cons4.269Citations (PDF)
41Cost-Effectiveness of MODY Genetic Testing: Translating Genomic Advances Into Practical Health Applications
Diabetes Care, 2014, 37, 202-209
10.1130Citations (PDF)
42Hyperinsulinism in a Neonate
Pediatric Annals, 2014, 43,
0.62Citations (PDF)
43Successful Transition From Insulin to Sulfonylurea Therapy in a Patient With Monogenic Neonatal Diabetes Owing to a KCNJ11 F333L Mutation
Diabetes Care, 2013, 36, e201-e201
10.17Citations (PDF)
44Gain-of-Function Mutations in the KATP Channel (KCNJ11) Impair Coordinated Hand-Eye Tracking
PLoS ONE, 2013, 8, e62646
2.47Citations (PDF)
45Visuomotor Performance in <i>KCNJ11</i>-Related Neonatal Diabetes Is Impaired in Children With DEND-Associated Mutations and May Be Improved by Early Treatment With Sulfonylureas
Diabetes Care, 2012, 35, 2086-2088
10.198Citations (PDF)
46Genetics and pathophysiology of neonatal diabetes mellitus2.988Citations (PDF)
47HLA-DQ haplotypes differ by ethnicity in patients with childhood-onset diabetes
Pediatric Diabetes, 2011, 12, 388-395
4.613Citations (PDF)
48Neonatal Diabetes: An Expanding List of Genes Allows for Improved Diagnosis and Treatment
Current Diabetes Reports, 2011, 11, 519-532
5.5106Citations (PDF)
49The Cost-Effectiveness of Personalized Genetic Medicine
Diabetes Care, 2011, 34, 622-627
10.186Citations (PDF)
50Update in neonatal diabetes2.337Citations (PDF)
51Neonatal diabetes mellitus: A model for personalized medicine8.876Citations (PDF)
52Tooth Discoloration in Patients With Neonatal Diabetes After Transfer Onto Glibenclamide: A previously unreported side effect
Diabetes Care, 2009, 32, 1428-1430
10.139Citations (PDF)
53Diagnosis and treatment of neonatal diabetes: an United States experience†
Pediatric Diabetes, 2008, 9, 450-459
4.6121Citations (PDF)
54Insulin gene mutations as a cause of permanent neonatal diabetes7.8520Citations (PDF)
55Educating Future Leaders of Medical Research: Analysis of Student Opinions and Goals from the MD???PhD SAGE (Students??? Attitudes, Goals, and Education) Survey
Academic Medicine, 2007, 82, 633-645
1.552Citations (PDF)
56MD-PhD Students in a Major Training Program Show Strong Interest in Becoming Surgeon-Scientists1.618Citations (PDF)
57The Role of T/B Lymphocyte Collaboration in the Regulation of Autoimmune and Alloimmune Responses
Immunologic Research, 2003, 27, 443-450
2.919Citations (PDF)
58Specialized CC-chemokine secretion by Th1 cells in destructive autoimmune myocarditis
Journal of Autoimmunity, 2003, 21, 295-303
6.817Citations (PDF)
59Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice
Nature Medicine, 2002, 8, 399-402
40.4191Citations (PDF)
60Impaired Activation of Islet-Reactive CD4 T Cells in Pancreatic Lymph Nodes of B Cell-Deficient Nonobese Diabetic Mice
Journal of Immunology, 2001, 167, 4351-4357
0.662Citations (PDF)
61In vivo MLR: a novel method for the study of alloimmune responses
Transplantation Proceedings, 1999, 31, 834-835
0.73Citations (PDF)
62Characterization of the alloimmune response to minor histocompatibility antigens by in vivo MLR
Transplantation Proceedings, 1999, 31, 836-837
0.73Citations (PDF)
63A DIRECT METHOD FOR THE CALCULATION OF ALLOREACTIVE CD4+ T CELL PRECURSOR FREQUENCY1
Transplantation, 1999, 67, 1281-1284
1.134Citations (PDF)
64CD28 COSTIMULATION IN ALLOIMMUNE RESPONSES AGAINST MAJOR AND MINOR HISTOCOMPATIBILITY ANTIGENS
Transplantation, 1999, 67, S598
1.19Citations (PDF)
65TRACKING ALLOREACTIVE CELL DIVISION IN VIVO1
Transplantation, 1999, 68, 297-299
1.117Citations (PDF)